These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11965965)

  • 1. Deadly risk of drug-resistant HIV.
    Gulland A
    Nurs Times; 2000 Dec 7-13; 96(49):6. PubMed ID: 11965965
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonadherence raises concerns over resistance.
    AIDS Alert; 1998 Sep; 13(9):108. PubMed ID: 11365793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accrued HIV evidence turns treatment dogma on its head.
    Check E
    Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

  • 5. ICAAC study on resistance.
    Burgess G
    Surviv News (Atlanta Ga); 2002 Feb; ():14. PubMed ID: 11870996
    [No Abstract]   [Full Text] [Related]  

  • 6. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV infection. Virus resistance: development and prevention].
    Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
    Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 9. The causes of HIV antiviral treatment failure.
    Clanon K
    Focus; 2001 Jun; 16(7):5-6. PubMed ID: 11548663
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicians' discussion: trends in HIV care.
    Braun J; el-Sadr W; Merrick S; Rubin D; Vogler M; Frost KR
    AIDS Read; 2000 Apr; 10(4):233-40. PubMed ID: 10808606
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow PI doses or don't prescribe them at all, researchers say.
    AIDS Alert; 1997 Apr; 12(4):37-40. PubMed ID: 11364144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the treatment-experienced patient.
    Gallant JE
    Infect Dis Clin North Am; 2007 Mar; 21(1):85-102, viii-ix. PubMed ID: 17502231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV drug resistance testing: data be damned.
    Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical data marshalled to treat HIV.
    Clarke T
    Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the difference between phenotyping and genotyping?
    Wilder TL
    Surviv News (Atlanta Ga); 2001 May; ():13, 20. PubMed ID: 11682727
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiretroviral resistance testing. A necessary element in the follow-up of the HIV-infected patient].
    Alcamí J; Rubio R
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):1-2. PubMed ID: 11428052
    [No Abstract]   [Full Text] [Related]  

  • 18. Outsmarting HIV.
    Fallon SJ
    Posit Aware; 2003; 14(2):37. PubMed ID: 12693374
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to antiretroviral therapy in resource-limited settings: everything matters.
    Hawkins C; Murphy R
    AIDS; 2007 May; 21(8):1041-2. PubMed ID: 17457099
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance. Navigating resistance pathways.
    Kuritzkes D
    AIDS Read; 2002 Sep; 12(9):395-400, 407. PubMed ID: 12402803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.